SuperworthAurinia Pharmaceuticals shares outstanding AUPH
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 133.5M
- On a year earlier
- −2.9%
- fewer shares
Aurinia Pharmaceuticals had 133.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.9% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 137.9M | −8% |
| FY2024 | 149.7M | +4% |
| FY2023 | 143.7M | +1% |
| FY2022 | 142.2M | +7% |
| FY2021 | 133.2M | +5% |
| FY2020 | 126.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 133.5M | −3% | |
| Q1 FY26 | 137.6M | −4% | |
| Q4 FY25 | 137.9M | −8% | |
| Q3 FY25 | 136M | −7% | |
| Q2 FY25 | 137.5M | −5% | |
| Q1 FY25 | 143.2M | −1% | |
| Q4 FY24 | 149.7M | +4% | |
| Q3 FY24 | 145.7M | +2% | |
| Q2 FY24 | 144.1M | +1% | |
| Q1 FY24 | 144M | +1% | |
| Q4 FY23 | 143.7M | +1% | |
| Q3 FY23 | 142.8M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Aurinia Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.